Gilead Sciences
GILD
$108.50
Share price
0.46%
Change (1 day)
53.53%
Change (1 year)
Categories
Gilead Sciences (GILD) - Net assets
Net assets on the balance sheet as of March 2025 : $19.07 Billion USD
According to Gilead Sciences's latest financial reports the company has $19.07 Billion USD in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Gilead Sciences - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $$19.24 B | -15.4% |
| 2023-12-31 | $$22.74 B | 7.26% |
| 2022-12-31 | $$21.20 B | 0.69% |
| 2021-12-31 | $$21.06 B | 15.6% |
| 2020-12-31 | $$18.22 B | -19.55% |
| 2019-12-31 | $$22.65 B | 5.18% |
| 2018-12-31 | $$21.53 B | 5.04% |
| 2017-12-31 | $$20.50 B | 5.88% |
| 2016-12-31 | $$19.36 B | 1.31% |
| 2015-12-31 | $$19.11 B | 20.82% |
| 2014-12-31 | $$15.81 B | 34.69% |
| 2013-12-31 | $$11.74 B | 23.07% |
| 2012-12-31 | $$9.54 B | 38.97% |
| 2011-12-31 | $$6.86 B | 12.18% |
| 2010-12-31 | $$6.12 B | -5.89% |
| 2009-12-31 | $$6.50 B | 45.67% |
| 2008-12-31 | $$4.46 B | 24.03% |
| 2007-12-31 | $$3.60 B | 92.65% |
| 2006-12-31 | $$1.86 B | -38.28% |
| 2005-12-31 | $$3.02 B | 61.84% |
| 2004-12-31 | $$1.87 B | 86.53% |
| 2003-12-31 | $$1.00 B | 75.55% |
| 2002-12-31 | $$0.57 B | 26.28% |
| 2001-12-31 | $$0.45 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.20 B | -67.47% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $16.49 B | -13.53% | 🇺🇸 USA |
 AbbVie ABBV | $1.46 B | -92.34% | 🇺🇸 USA |
 Illumina ILMN | $2.36 B | -87.59% | 🇺🇸 USA |
 Biogen BIIB | $16.97 B | -11.00% | 🇺🇸 USA |
 Pfizer PFE | $90.63 B | 375.09% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $78.10 B | 309.42% | 🇺🇸 USA |
 Eli Lilly LLY | $15.84 B | -16.94% | 🇺🇸 USA |
 Merck MRK | $48.40 B | 153.70% | 🇺🇸 USA |